XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma

.

Source: Expert Opinion on Therapeutic Targets - December 11, 2023 Category: Drugs & Pharmacology Authors: Zahra HendiPedram Asadi SarabiDavid HayMassoud Vosougha Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iranb Dep Source Type: research